SLC12A5 and glioma: As molecular subtypes were applied to differ survival ability in glioma patients where PN and CL had better prognosis than MES subtype,15 we also investigated their associations and found that MES subtype preferred low expression level of SLC12A5 in all four cohorts (Figure 2B, Figure S1E).